Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection

被引:58
作者
Wang, Dai [1 ]
Li, Fengsheng [1 ]
Freed, Daniel C. [1 ]
Finnefrock, Adam C. [1 ]
Tang, Aimin [1 ]
Grimes, Shannon N. [1 ]
Casimiro, Danilo R. [1 ]
Fu, Tong-Ming [1 ]
机构
[1] Merck Res Labs, Dept Vaccine Res, West Point, PA 19486 USA
关键词
Cytomegalovirus; Neutralizing antibody; Vaccines; Epithelial cells; Natural infection; Biomarker; ENDOTHELIAL-CELLS; IMMUNITY; WOMEN; HCMV; PREVENTION; LEUKOCYTES; MORTALITY; COMPLEX; TOWNE; GENES;
D O I
10.1016/j.vaccine.2011.09.056
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Naturally acquired immunity significantly reduces the risk of congenital cytomegalovirus (CMV) infection in future pregnancies. An immune response comparable to that of natural infection has been used as a benchmark for CMV vaccine efficacy; however, the magnitude and persistence of the neutralizing antibody responses in naturally infected women are not completely understood. In this study, we quantitatively analyzed a panel of 375 female CMV convalescent sera ranging in age from 18 to 84 years, for its ability to block virus entry into epithelial cells and fibroblasts, as well as Its binding potential to CMV particles. The geometric mean titer of the sera in this panel to neutralize 50% of the virus entry into epithelial cells was 7491, compared to 802 for entry into fibroblasts. The epithelial neutralizing titers were statistically indistinguishable among different: age groups, and conformed to a normal distribution. There was a weak correlation between the levels of neutralization and the binding activities to viral particles. Our data confirmed that natural CMV infection in healthy women induces potent neutralizing antibodies against infection of both fibroblasts and epithelial cells. The serum neutralizing activities were maintained at high levels throughout the child bearing age. The corresponding titers may serve as a biomarker for CMV vaccine efficacy. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:9075 / 9080
页数:6
相关论文
共 37 条
  • [1] IMMUNITY INDUCED BY PRIMARY HUMAN CYTOMEGALOVIRUS-INFECTION PROTECTS AGAINST SECONDARY INFECTION AMONG WOMEN OF CHILDBEARING AGE
    ADLER, SP
    STARR, SE
    PLOTKIN, SA
    HEMPFLING, SH
    BUIS, J
    MANNING, ML
    BEST, AM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) : 26 - 32
  • [2] Safety and immunogenicity of the Towne strain cytomegalovirus vaccine
    Adler, SP
    Hempfling, SH
    Starr, SE
    Plotkin, SA
    Riddell, S
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (03) : 200 - 206
  • [3] Vaccine development to prevent cytomegalovirus disease: Report from the National Vaccine Advisory Committee
    Arvin, AM
    Fast, P
    Myers, M
    Plotkin, S
    Rabinovich, R
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (02) : 233 - 239
  • [4] Human cytomegalovirus UL131A, UL130 and UL128 genes are highly conserved among field isolates
    Baldanti, F.
    Paolucci, S.
    Campanini, G.
    Sarasini, A.
    Percivalle, E.
    Revello, M. G.
    Gerna, G.
    [J]. ARCHIVES OF VIROLOGY, 2006, 151 (06) : 1225 - 1233
  • [5] High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169
    Bradley, Amanda J.
    Lurain, Nell S.
    Ghazal, Peter
    Trivedi, Urmi
    Cunningham, Charles
    Baluchova, Katarina
    Gatherer, Derek
    Wilkinson, Gavin W. G.
    Dargan, Derrick J.
    Davison, Andrew J.
    [J]. JOURNAL OF GENERAL VIROLOGY, 2009, 90 : 2375 - 2380
  • [6] CELL-SURFACE EXPRESSION OF HUMAN CYTOMEGALOVIRUS (HCMV) GP55-116 (GB) - USE OF HCMV-RECOMBINANT VACCINIA VIRUS-INFECTED CELLS IN ANALYSIS OF THE HUMAN NEUTRALIZING ANTIBODY-RESPONSE
    BRITT, WJ
    VUGLER, L
    BUTFILOSKI, EJ
    STEPHENS, EB
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (03) : 1079 - 1085
  • [7] CUI X, 2010, 35 ANN INT HERP WORK
  • [8] Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection
    Cui, Xiaohong
    Meza, Benjamin P.
    Adler, Stuart P.
    McVoy, Michael A.
    [J]. VACCINE, 2008, 26 (45) : 5760 - 5766
  • [9] Maternal immunity and prevention of congenital cytomegalovirus infection
    Fowler, KB
    Stagno, S
    Pass, RF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (08): : 1008 - 1011
  • [10] THE OUTCOME OF CONGENITAL CYTOMEGALOVIRUS-INFECTION IN RELATION TO MATERNAL ANTIBODY STATUS
    FOWLER, KB
    STAGNO, S
    PASS, RF
    BRITT, WJ
    BOLL, TJ
    ALFORD, CA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (10) : 663 - 667